We are live on ! Find out more
HUMA icon

Humacyte
HUMA

78 hedge funds and large institutions have $43.1M invested in Humacyte in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

11% more funds holding

Funds holding: 70 → 78 (+8)

2.86% more ownership

Funds ownership: 10.18% → 13.05% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

42% less capital invested

Capital invested by funds: $74M → $43.1M (-$30.9M)

59% less call options, than puts

Call options by funds: $332K | Put options by funds: $806K

Holders
78
Holders Change
+8
Holders Change %
+11.43%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
27
Reduced
17
Closed
13
Calls
$332K
Puts
$806K
Net Calls
-$474K
Net Calls Change
-$782K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$6.12M
2
BlackRock
BlackRock
New York
+$4.55M
3
LPL Financial
LPL Financial
California
+$1.65M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.4M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$991K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$867K
2
ECM
ExodusPoint Capital Management
New York
-$745K
3
Squarepoint
Squarepoint
New York
-$420K
4
WAM
Weiss Asset Management
Massachusetts
-$352K
5
PGP
Prescott General Partners
Florida
-$316K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
76
ExodusPoint Capital Management
New York
– -$745K -105,525 Closed
Squarepoint
77
Squarepoint
New York
– -$420K -59,531 Closed
WAM
78
Weiss Asset Management
Massachusetts
– -$352K -49,900 Closed
Simplex Trading
79
Simplex Trading
Illinois
– -$185K -33,351 Closed
KA
80
Kovack Advisors
Florida
– -$222K -31,500 Closed
SM
81
Sciencast Management
New Jersey
– -$182K -26,300 Closed
Balyasny Asset Management
82
Balyasny Asset Management
Illinois
– -$122K -17,272 Closed
YIH
83
Y-Intercept (HK)
Hong Kong
– -$121K -17,125 Closed
Teacher Retirement System of Texas
84
Teacher Retirement System of Texas
Texas
– -$75K -10,554 Closed
EP
85
Eudaimonia Partners
Tennessee
– -$73K -10,302 Closed
MFS
86
Mirabella Financial Services
United Kingdom
– -$72K -10,244 Closed
Royal Bank of Canada
87
Royal Bank of Canada
Ontario, Canada
– -$13.1K -2,348 -96%
OCM
88
Ovata Capital Management
Hong Kong
– -$6K -800 Closed
HR
89
Howe & Rusling
New York
– -$1K -200 Closed
UWM
90
Urban Wealth Management
California
– +$61 +11 New
Fidelity Investments
91
Fidelity Investments
Massachusetts
– +$423 +76 New
1 2 3
4

HUMA Hedge Fund Activity: Q2 2022 in Review

78 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2022, worth a combined $43.1M — down 42% from $74M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new HUMA positions and 13 closed out — a net gain of 9 holders — while 27 added to existing stakes and 17 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $6.12M. The largest seller was Susquehanna International Group, cutting an estimated $867K.

  • 78 institutional investors held Humacyte (HUMA) as of Q2 2022, up from 70 in Q1 2022.
  • Funds reported $43.1M of Humacyte stock for Q2 2022, down 42% quarter-over-quarter.
  • 22 funds opened new Humacyte positions in Q2 2022 and 13 closed out, a net change of +9 holders.
  • The largest Humacyte buyer in Q2 2022 was UBS O'Connor, an estimated $6.12M added.
  • The largest Humacyte seller in Q2 2022 was Susquehanna International Group, an estimated $867K sold.

Based on aggregated 13F filings for Q2 2022.